Beckwith–Wiedemann syndrome is an overgrowth disorder characterized by neonatal
macrosomia, abdominal wall defects, macroglossia, renal anomalies, organomegaly …

Beckwith–Wiedemann syndrome (BWS) is the most common (epi) genetic overgrowth-
cancer predisposition disorder. Given the absence of consensual recommendations or …

Dysregulation of imprinted genes on human chromosome 11p15 has been implicated in
Beckwith–Wiedemann syndrome (BWS), an overgrowth syndrome associated with …

Recently Brzezinski et al. reported three individuals with Beckwith–Wiedemann syndrome
(BWS) due to a loss of methylation at imprinting center 2 (IC2 LOM), who had intra …

Abstract Patients with Beckwith‐Wiedemann spectrum (BWSp) undergo quarterly alpha‐
fetoprotein measurement for hepatoblastoma (HB) screening up to 4 years of age …

Abstract Beckwith–Wiedemann Syndrome (BWS) is an overgrowth syndrome caused by a
variety of molecular changes on chromosome 11p15. 5. Children with BWS have a …

Beckwith-Wiedemann syndrome (BWS) is a human genomic imprinting disorder that
presents with a wide spectrum of clinical features including overgrowth, abdominal wall …

1. Background Beckwith–Wiedemann syndrome (BWS) is also termed EMG (exomphalos,
macroglossia, and gigantism) syndrome. Historically, the first clinical description was in …

Background Constitutional or somatic mosaic epimutations are increasingly recognized as a
mechanism of gene dysregulation resulting in cancer susceptibility. Beckwith‐Wiedemann …

Since 1993, our Institution has recommended that patients with the BeckwithąWiedemann
syndrome BWS) be screened for Wilms tumor with periodic abdominal ultrasonograms. We …